 |
|
Notice of Duplicate Publication
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
To the Editor: I am writing in response to notification that original data from our recent JAMA article1 were previously published in a review article by Mathur.2
I was involved from the outset of the ziconotide trial, including the design, collection, and analysis of data and the drafting of the initial manuscript. Since 1995, I was a funded investigator on this study at Johns Hopkins University. The initial draft of our manuscript was sent to Neurex/Elan (the sponsors of our trial) by my coauthors and me around 1998, well before Dr Mathur, a former employee of Elan, published her review in June 2000. Her submission was sent without my permission or notification and without citing my coauthors or me.
We submitted our article to JAMA as a primary publication in May 2003. Before submission, our in-house manuscript used a reference to an abstract by Brose et al,3 and in our . . . [Full Text of this Article]
Peter S. Staats, MD
pstaats@jhmi.edu
Division of Pain Medicine
Johns Hopkins University School of Medicine
Baltimore, Md
RELATED ARTICLES
Duplicate Publication, Multiple Problems
Catherine D. DeAngelis
JAMA. 2004;292(14):1745-1746.
EXTRACT
| FULL TEXT
Intrathecal Ziconotide in the Treatment of Refractory Pain in Patients With Cancer or AIDS: A Randomized Controlled Trial
Peter S. Staats, Thomas Yearwood, Steven G. Charapata, Robert W. Presley, Mark S. Wallace, Michael Byas-Smith, Robert Fisher, David A. Bryce, Eugene A. Mangieri, Robert R. Luther, Martha Mayo, Dawn McGuire, and David Ellis
JAMA. 2004;291(1):63-70.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Duplicate Publication, Multiple Problems
DeAngelis
JAMA 2004;292:1745-1746.
FULL TEXT
|
